MannKind Corp (MNKD)
4.15
+0.04
(+0.97%)
USD |
NASDAQ |
Apr 23, 16:00
4.155
0.00 (0.00%)
After-Hours: 20:00
MannKind Enterprise Value: 1.096B for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 1.096B |
| April 22, 2024 | 1.085B |
| April 19, 2024 | 1.104B |
| April 18, 2024 | 1.077B |
| April 17, 2024 | 1.082B |
| April 16, 2024 | 1.069B |
| April 15, 2024 | 1.088B |
| April 12, 2024 | 1.096B |
| April 11, 2024 | 1.136B |
| April 10, 2024 | 1.120B |
| April 09, 2024 | 1.174B |
| April 08, 2024 | 1.204B |
| April 05, 2024 | 1.174B |
| April 04, 2024 | 1.139B |
| April 03, 2024 | 1.172B |
| April 02, 2024 | 1.139B |
| April 01, 2024 | 1.147B |
| March 28, 2024 | 1.199B |
| March 27, 2024 | 1.226B |
| March 26, 2024 | 1.301B |
| March 25, 2024 | 1.299B |
| March 22, 2024 | 1.304B |
| March 21, 2024 | 1.261B |
| March 20, 2024 | 1.277B |
| March 19, 2024 | 1.236B |
| Date | Value |
|---|---|
| March 18, 2024 | 1.223B |
| March 15, 2024 | 1.182B |
| March 14, 2024 | 1.190B |
| March 13, 2024 | 1.215B |
| March 12, 2024 | 1.177B |
| March 11, 2024 | 1.220B |
| March 08, 2024 | 1.399B |
| March 07, 2024 | 1.366B |
| March 06, 2024 | 1.272B |
| March 05, 2024 | 1.258B |
| March 04, 2024 | 1.231B |
| March 01, 2024 | 1.190B |
| February 29, 2024 | 1.085B |
| February 28, 2024 | 1.034B |
| February 27, 2024 | 995.78M |
| February 26, 2024 | 941.70M |
| February 23, 2024 | 933.58M |
| February 22, 2024 | 944.40M |
| February 21, 2024 | 947.11M |
| February 20, 2024 | 947.11M |
| February 16, 2024 | 960.63M |
| February 15, 2024 | 975.43M |
| February 14, 2024 | 945.72M |
| February 13, 2024 | 891.72M |
| February 12, 2024 | 964.63M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
247.88M
Minimum
Jun 26 2019
1.593B
Maximum
Aug 08 2023
908.61M
Average
1.045B
Median
Jun 15 2022
Enterprise Value Benchmarks
| Cassava Sciences Inc | 766.06M |
| NovaBay Pharmaceuticals Inc | 2.275M |
| Palatin Technologies Inc | 18.75M |
| iBio Inc | 16.49M |
| Theriva Biologics Inc | -13.75M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.401M |
| Revenue (Quarterly) | 58.47M |
| Total Expenses (Quarterly) | 47.84M |
| EPS Diluted (Quarterly) | 0.01 |
| Gross Profit Margin (Quarterly) | 69.10% |
| Profit Margin (Quarterly) | 2.40% |
| Earnings Yield | -0.96% |
| Operating Earnings Yield | 0.91% |
| Normalized Earnings Yield | -0.8185 |